Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -10.85% is 89% above its 5-year average of -102.76%, near the high end of its 5-year range (-305.19%–-10.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 78.79% above its 12-month average of -51.13%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -10.85%.
RETURN ON INVESTED CAPITAL (ROIC)
-10.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-131.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-102.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-71.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-66.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+78.79%
CURRENT VS 3Y AVG
+91.78%
CURRENT VS 5Y AVG
+89.45%
CURRENT VS 10Y AVG
+84.80%
CURRENT VS 15Y AVG
+83.67%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 663 covered companies
CURRENT VS SECTOR MEDIAN
+67.62%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$69.26M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-51.13%
3Y Avg
-131.92%
5Y Avg
-102.76%
Market Cap
$68.77M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
Market Cap
$68.81M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$70.95M
Return on Invested Capital (ROIC)
-153.46%
TTM Avg
-63.13%
3Y Avg
-47.00%
5Y Avg
-35.71%
Market Cap
$66.42M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$66.02M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$64.13M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$63.78M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
Market Cap
$74.00M
Return on Invested Capital (ROIC)
-159.24%
TTM Avg
-170.07%
3Y Avg
-147.54%
5Y Avg
-112.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $69.26M | -10.85% | -51.13% | -131.92% | -102.76% |
| Champions Oncology, Inc. (CSBR)vs › | $68.77M | -6.75% | 20.47% | -36.30% | -23.36% |
| iBio, Inc. (IBIO)vs › | $68.81M | -40.22% | -72.23% | -74.75% | -58.95% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.95M | -153.46% | -63.13% | -47.00% | -35.71% |
| Gossamer Bio, Inc. (GOSS)vs › | $66.42M | N/A | -86.10% | -83.22% | -74.34% |
| Cingulate Inc. (CING)vs › | $66.02M | -83.74% | -153.15% | -164.21% | -165.99% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.13M | -6.79% | -4.87% | -47.70% | -62.00% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | -56.22% | -67.31% | -52.91% | -45.67% |
| Gain Therapeutics, Inc. (GANX)vs › | $74.00M | -159.24% | -170.07% | -147.54% | -112.39% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.26M | -52.40% | -44.92% | -44.92% | -44.02% |
ROIC
-10.8%
ROE
68.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -10.85% |
| 2026-03-31 | -21.09% |
| 2025-12-31 | -51.83% |
| 2025-09-30 | -69.90% |
| 2025-06-30 | -101.98% |
| 2025-03-31 | -93.67% |
| 2024-12-31 | -154.93% |
| 2024-09-30 | -182.77% |
| 2024-06-30 | -133.61% |
| 2024-03-31 | -138.66% |
| 2023-12-31 | -166.25% |
| 2023-09-30 | -284.20% |
| 2023-06-30 | -305.19% |
| 2023-03-31 | -151.86% |
| 2022-12-31 | -115.16% |
| 2022-09-30 | -93.18% |
| 2022-06-30 | -78.84% |
| 2022-03-31 | -64.73% |
| 2021-12-31 | -61.44% |
| 2021-09-30 | -46.04% |
| 2021-06-30 | -34.21% |
| 2021-03-31 | -29.83% |
| 2020-12-31 | -32.73% |
| 2020-09-30 | -38.80% |
| 2020-06-30 | -42.77% |
| 2020-03-31 | -52.07% |
| 2019-12-31 | -58.94% |
| 2019-09-30 | -60.15% |
| 2019-06-30 | -60.00% |
| 2019-03-31 | -74.68% |
| 2018-12-31 | -117.56% |
| 2018-09-30 | -66.50% |
| 2018-06-30 | -64.77% |
| 2018-03-31 | -59.38% |
| 2017-12-31 | -52.78% |
| 2017-09-30 | -48.84% |
| 2017-06-30 | -37.64% |
| 2017-03-31 | -41.49% |
| 2016-12-31 | -56.55% |
| 2016-09-30 | -55.32% |
| 2016-06-30 | -72.77% |
| 2016-03-31 | -56.92% |
| 2015-12-31 | -46.77% |
| 2015-09-30 | -54.67% |
| 2015-06-30 | -37.02% |
| 2015-03-31 | -30.93% |
| 2014-12-31 | -24.22% |
| 2014-09-30 | -29.86% |
| 2014-06-30 | -32.45% |
| 2014-03-31 | -37.44% |
| 2013-12-31 | -37.44% |
| 2013-09-30 | -33.38% |
| 2013-06-30 | -51.03% |
| 2013-03-31 | -68.40% |
| 2012-12-31 | -75.78% |
| 2012-09-30 | -55.27% |
| 2012-06-30 | -63.09% |
| 2012-03-31 | -134.37% |
| 2011-12-31 | -176.26% |
| 2011-09-30 | -139.32% |
